CD4 and neoplasm: Gujam et al. described the relationship between TSR and clinicopathological parameters as tumor inflammatory infiltrate, CD68+ macrophage infiltrate and CD4+ and CD8+ T-lymphocyte infiltrate in ductal breast cancer.